Stock Splits
By The Online Investor Staff, updated Fri., Oct. 22, 3:54 AM
| This Slide: #6 of 25 |
Slide #6. Jaguar Health, Inc. (NASDAQ:JAGX) — 1 for 3 Reverse Split
Announced:
9/3/2021
Stock Split:
1 for 3
Record Date:
9/7/2021
Pay Date:
9/8/2021
JAGX Optionable?:
Yes
Jaguar Health is a commercial stage plant medicine prescription pharmaceutical company focused on developing and commercializing gastrointestinal products on a global basis. Co.'s wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used in rainforest areas. Co.'s Mytesi (crofelemer) product is approved by the U.S. Food and Drug Administration for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. In addition, a second-generation proprietary anti-secretory agent, lechlemer, is in development for cholera. 
JAGX Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the JAGX Page at The Online Investor (in a new window) »
 Free JAGX Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 86th percentile
(ranked higher than approx. 86% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
